0001140361-16-069010.txt : 20160607 0001140361-16-069010.hdr.sgml : 20160607 20160607210734 ACCESSION NUMBER: 0001140361-16-069010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160606 FILED AS OF DATE: 20160607 DATE AS OF CHANGE: 20160607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOULWAN GEORGE A CENTRAL INDEX KEY: 0001222197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 161702549 4 1 doc1.xml FORM 4 X0306 4 2016-06-06 0 0001367644 Emergent BioSolutions Inc. EBS 0001222197 JOULWAN GEORGE A 400 PROFESSIONAL DRIVE, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2016-06-06 4 S 0 4700 44.12 D 20785 D Consists of vested restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.10 to $44.15. /s/ Eric Burt, Attorney-in-fact 2016-06-07